Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74

Published:2003-10 Issue:7 Volume:30 Page:715-723
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Michel Rosana B.,Rosario Adriane V.,Brechbiel Martin W.,Jackson Thomas J.,Goldenberg David M.,Mattes M.Jules

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference36 articles.

1. Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules;Adams;Nucl Med Biol,2000

2. Dose-survival curves of human cells in tissue culture irradiated with alpha-, beta-, 20-kV, X- and 200 kV. X-radiation;Barendsen;Nature,1962

3. High-linear energy transfer (LET) α versus low-LET β emiters in radioimmunotherapy of solid tumors;Behr;Cancer Res,1999

4. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair;Biedermann;Proc Natl Acad Sci USA,1991

5. Optimizations of radiolabeling of immunoproteins with 213Bi;Boll;Radiochimica Acta,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using²¹³Bi-Anti-CD20 Monoclonal Antibody;Journal of Nuclear Medicine;2022-08-18

2. Radiolabeled Antibodies for Cancer Radioimmunotherapy;Nuclear Medicine and Immunology;2021-11-25

3. Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies;Cancer Biotherapy and Radiopharmaceuticals;2020-09-01

4. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab′)2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival;Journal of Nuclear Medicine;2016-09-29

5. Radioimmunotherapy for B-Cell Non-Hodgkin Lymphomas;Cancer Control;2012-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3